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ABSTRACT
Background: To compare the short-term anatomical and functional outcomes of, as well as patient satisfaction 
with, lacrimal stenting and three-snip punctoplasty for the treatment of punctal stenosis or occlusion.
Methods: In this open-label, randomized clinical trial, we included 50 eyes of 30 patients diagnosed with punctal 
stenosis or occlusion. They were randomly allocated to two groups of 25 eyes each, using central telephone 
randomization. Group A underwent a lacrimal stenting procedure and was subdivided into two subgroups: 
Group A1 (13 eyes) received polyvinylpyrrolidone-coated perforated punctal plugs, and Group A2 (12 eyes) 
received closed intubation using a bicanalicular silicon tube. Group B included 25 eyes that underwent three-
snip punctoplasty. All eyes were examined after 1 day, 1 week, 1 month, 3 months, and 6 months. Postoperative 
anatomical success assessing the punctum size, functional success using the fluorescein disappearance test, and 
patient satisfaction based on epiphora scoring were recorded.
Results: Both study groups were comparable in terms of sex and age distribution. Compared to Group B, 
Group A had a significantly larger punctum size at one, three, and 6-month postoperatively (P = 0.009, 0.01, and 
0.02, respectively). The difference in FDT results was significant between the two groups at all follow-up visits 
(P = 0.008, 0.0001, 0.003, and 0.002, at postoperative one week, one-months, three-month, and six-month, 
respectively). Likewise, patient satisfaction was significantly different between both groups at all follow-up 
visits (P = 0.007, 0.001, 0.005, and 0.002, at postoperative one week, one-months, three-month, and six-month, 
respectively).
Conclusions: Lacrimal stenting is an effective method for the treatment of punctal stenosis or occlusion. 
Overall, the FDT results and patient satisfaction outcomes were significantly better.
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INTRODUCTION
Epiphora is one of the most frequent complaints encountered by ophthalmologists and has a wide range of 
differential diagnoses. Patients complaining of epiphora usually present with watery eyes, burning sensation, and 
eye discomfort. Upper or lower tear-drainage stenosis is one etiological factor of epiphora [1]. 
The lower punctum is usually located 0.5–1 mm lateral to the upper punctum on top of the lacrimal papilla, 
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with a surrounding fibrous ring [2]. Punctal stenosis can be congenital or acquired, with a broad spectrum of 
etiologies that include trauma; dry eye disease; inflammatory diseases, such as blepharitis; lid margin malposition, 
mainly ectropion; and age-related changes. It can also develop secondary to radiotherapy or use of topical eye 
drops, such as antiglaucoma medications [2, 3]. Diagnostic procedures include slit-lamp examination to assess 
the size and location of the punctum, and examination of the lid margin and conjunctiva for chronic diseases, 
such as blepharitis or lid margin malposition. In addition, the fluorescein dye disappearance test (FDT) shows 
delayed dye disappearance in cases of punctal stenosis. The inability to introduce a 26-gauge lacrimal cannula 
without dilation is also a diagnostic test for punctual stenosis [4, 5].
At present, surgeons mostly treat punctal stenosis using punctoplasty (one-, two-, or three-snip punctoplasty) 
or combined punctal dilation with mitomycin C application. Furthermore, stenting procedures are becoming 
more popular and should be preceded by punctal dilation, followed by placement of Mini Monoka stents. In 
this context, the use of perforated punctal plugs is promising [6-8]. The most common cause of treatment failure 
involves epiphora recurrence due to restenosis or fibrosis. Other complications include plug extrusion and 
granuloma formation [9]. 
The aim of this open-label, randomized clinical trial was to compare the short-term anatomical and functional 
outcomes of, as well as the patient satisfaction with, lacrimal stenting and punctoplasty for the treatment of 
punctal stenosis or occlusion. 
METHODS
This open-label, randomized clinical trial received institutional review board (IRB) approval from the Faculty 
of Medicine, Sohag University, Egypt, before conducting the study. This clinical trial was registered at the Pan 
African Clinical Trial Registry (PACTR; registration number PACTR201801002952201) and was conducted 
in accordance with the tenets of the Declaration of Helsinki. All participants provided informed consent after 
receiving an explanation of the study procedures. 
The primary outcome was the patency of the punctum 6 months after the primary surgery. Secondary outcomes 
included functional success and patient satisfaction based on epiphora scoring at 6-months postoperatively. 
Fifty eyes of 30 patients with epiphora, who were diagnosed with punctal stenosis or occlusion and who 
underwent surgical intervention at Sohag university hospital, between October 2016 and April 2018, were 
included. The preoperative evaluation included recording a detailed medical and ocular history, including drug 
history (topical or systemic medications), medical or surgical history, demographics, main symptoms, and onset 
of epiphora. All participants underwent ophthalmological evaluation, including a detailed slit-lamp examination 
(SL-3 slit-lamp, ChongQing SunKingdom Medical Instrument Co. Ltd, China), to detect any associated 
ocular pathology, and to determine the degree of punctal occlusion. Furthermore, syringing and probing were 
conducted to exclude any associated lacrimal pathway obstruction. Preoperative punctal stenosis was graded 
using the Kashkouli et al. [1] grading scheme; grades 0‒5, defined as no punctum or atresia; papilla covered with 
a membrane or fibrosis and difficult to recognize; punctum recognizable but smaller than normal; normal; small 
slit (< 2 mm); and large slit (≥ 2 mm), respectively. Patients with other lacrimal drainage system pathologies, 
such as canalicular or nasolacrimal duct obstruction, were excluded. 
Participants were randomly assigned to Groups A and B (Figure 1), using central telephone randomization. 
Group A included 25 eyes Figure, which were further randomly subdivided into subgroups A1 and A2. Eyes 
in Subgroup A1 (13 eyes) were subjected to lacrimal stenting by insertion of perforated punctal plugs (FCI 
Ophthalmics Company, Paris, France) (Figure 2). These plugs are coated with polyvinylpyrrolidone to have a 
perfectly smooth surface, and have a slanted collarette to ensure perfect anatomical fit against the eyelid margin. 
They are preloaded on a sterile, disposable, single-use plug inserter. Eyes in Subgroup A2 (12 eyes) were subjected 
to lacrimal stenting involving closed intubation of a bicanalicular silicone tube (Eagle Labs, Rancho Cucamonga, 
CA, USA). Group B included 25 eyes that underwent three-snip punctoplasty. 
Twenty patients underwent bilateral surgery, and 10 underwent unilateral surgery at Sohag University Hospital, 
performed by a single surgeon (A.M.I). The postoperative treatment regimen was similar for all participants, 
including 0.5% moxifloxacin ophthalmic solution (VIGAMOX, Alcon Laboratories, Inc., Fort Worth, TX), 1% 
topical prednisolone acetate (Econopred Plus, Alcon Laboratories, Inc.), and lubricating eye drops (Systane 
Ultra, Alcon Laboratories, Inc.). Additionally, aceclofenac 100 mg tablets twice daily (Bristol-Myers Squibb, 
BMS, NY, USA) was used for adults, and ibuprofen syrup (Brufen 600, Abbott Laboratories, Abbott Park, IL, 
USA) twice daily was used in children, for 1 week. Moreover, cefadroxil (Smithkline Beecham Egypt, LLC, 
Cairo, Egypt; 500 mg tablet for adults and 250 mg for children) was used twice daily.
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Patients were examined on the first postoperative day, and postoperative visits were then scheduled at 1 week, 1 
month, 3 months, and 6 months. Recurrence of epiphora and the degree of patient satisfaction based on epiphora 
scoring were recorded at each follow-up visit. At follow-up visits, epiphora was scored using a combination of the 
Munk score [10] and the epiphora score described by Malet et al. [11]: score 0 (no tearing), score 1 (transient 
tearing outside in windy weather), score 2 (constant tearing, sometimes requiring wiping), and score 3 (constant 
tearing, requiring wiping). 
Slit-lamp examination was performed, and the patency of the punctum was checked postoperatively. We graded 
the postoperative punctal patency as follows: grade 0 was assigned if the punctum was difficult to recognize with 
the punctal dilator or was totally covered with a membrane or fibrosis; grade 1 was assigned if the punctum was 
smaller than the normal size but was recognizable and punctal dilation was required; and grade 2 was assigned if 
the punctum was open and no interventions were required [1]. Subsequently, the FDT was performed to assess 
the postoperative functional success by instillation of a drop of 2% fluorescein. Three and 5 minutes later, the dye 
remaining in the tear meniscus was assessed and graded as Grade 1, Grade 2, and Grade 3 if the dye disappeared 
in < 3 min, in 3–5 min, and in > 5 min, respectively [5]. Furthermore, on slit-lamp examination at each follow-up 
visit, we recorded the tear meniscus height, presence of congested conjunctival blood vessels, and lower lid skin 
maceration, if present. In Group A1, perforated punctal plugs were removed 3 months after surgery, and in Group 
A2, the bicanalicular silicon tube was removed after 6 months.
Statistical analysis was performed using SPSS Statistics for Windows (version 16.0; SPSS Inc., Chicago, IL, 
USA). Statistical analysis was performed by a person who was masked to the intervention arms. The independent 
t-test was used to assess the statistical significance of differences in predetermined parameters between the 
groups, and a paired-t test was used to assess the statistical significance of differences within the same group. 
Differences were considered statistically significant if P < 0.05, and highly significant if P < 0.01.
RESULTS 
Groups A and B were comparable in terms of sex and age distribution. In Group A, seven patients (41%) were 
men and 10 (59%) were women; in Group B, seven patients (54%) were men and 6 (46%) were women (P = 
0.46). The mean ± standard deviation of age was 34.32 ± 9.11 years, and 40.54 ± 7.66 years in Groups A and B, 
respectively (P = 0.08). Table 1 summarizes the patency of the punctum in all follow-up visits. It was graded as 
open, stenotic, and closed. During the 1-, 3-, and 6-month follow-up visits, significant differences were found 
between groups A and B (P = 0.030, P = 0.002, and P = 0.002, respectively).
Table 2 shows a comparison of patients’ satisfaction, based on epiphora scoring, between Groups A and B at 
the follow-up visits. At all follow-up visits, there were statistically significant differences between the two groups 
(P = 0.007, P = 0.001, P = 0.005, and P = 0.002, at 1-week, 1-month, 3-months, and 6-months, respectively).
Table 3 shows the mean external punctal size and outcomes of FDT at all follow-up visits. As shown in Table 
3, compared to Group B, Group A had a significantly larger punctum size at 1-, 3-, and 6-months postoperatively 
(P = 0.009, P = 0.010, and P = 0.020, respectively). In Group A, FDT was < 5 min (grade 1 or 2) in 24 eyes at 
1-month, and < 5 min at 6-months postoperatively in 20 eyes. In Group B, after 6 months, 12 eyes showed some 
degree of stenosis, with FDT > 5 min and in 13 eyes FDT was < 5 min. As shown in Table 3, the difference in 
FDT results was significant between the two groups at all follow-up visits (P = 0.008, 0.0001, 0.003, and 0.002, 
at 1-week, 1-month, 3-months, and 6-months, respectively).
In terms of postoperative complications, 36% of the eyes in Group A showed some degree of stenosis, while 
stenosis was found in 48% of the eyes in Group B by 6-months postoperatively. The punctum was occluded 
in only one eye in Group B. In Group A1, loss of perforated punctal plugs was found in two eyes, and partial 
extrusion of perforated punctal plugs was found in one eye. In Group A2, lacrimal tube prolapse was found in 
one eye and cheese wiring was found in another eye. No eyes in Group B showed canalicular injury or lacrimal 
pump failure.
DISCUSSION
Our study demonstrated the superiority of lacrimal stenting procedures over three-snip punctoplasty. 
Furthermore, closed lacrimal intubation with a silicon tube yielded statistically significantly better postoperative 
improvements than perforated punctal plug insertion, including more effective punctal patency, greater external 
punctum size, and higher patient satisfaction. This study found that closed lacrimal intubation was the best 
procedure, followed by insertion of perforated punctal plugs and then three-snip punctoplasty. 
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All participants attended follow-up visits at 1-
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♦ Did not receive allocated intervention (N = 0) 
Analyzed (N = 25 eyes) 





Randomization (N = 50 eyes) 
Enrollment 
Figure 1. Patient allocation to Group A (lacrimal stenting) or Group B (three-snip punctoplasty).
In a study by Shahid et al. [12] on the outcomes of punctoplasty, the functional and anatomical success rates for 
punctoplasty surgery were 64% and 91%, respectively. The patient satisfaction rate was 71%. Anatomical success 
was comparable between two-snip and three-snip punctoplasty [12]. On the other hand, our study recorded a 
lower patient satisfaction rate with no tearing or sometimes tearing, which was 64% and 52% at 3- and 6-months 
postoperatively, respectively.
Punctum and canalicular stent insertion was introduced to improve the success rate of epiphora or punctal 
stenosis treatment. It has the advantage that it can treat both punctal and canalicular stenosis simultaneously, 
which is important, as up to 45% of punctal stenosis cases are associated with canalicular stenosis. Stent insertion 
nullifies the need for a snip procedure, thus reducing the risk of fibrosis and restenosis [13]. Hussain et al. found 
improvement in epiphora in 82% of 77 eyes at 6 weeks in patients who underwent punctal dilation with Mini 
Monoka tube insertion, without snip procedures. However, they reported premature stent loss in three patients 
and stent migration in one patient at the 6-week follow-up [14]. Our study demonstrated the superiority of 
lacrimal stenting procedures over three-snip punctoplasty with significantly better short-term anatomical and 
functional outcomes, as well as patient satisfaction.
In acquired punctal stenosis of 44 eyes managed by inserting a perforated punctal plug, the success rate for 
the improvement of epiphora was 84.1% (37 of 44 eyes) [15]. Moreover, the success rate reported by Chang et 
al. [16] was 85% in a series of 20 eyes. In our study, perforated punctal plugs coated with polyvinylpyrrolidone 
were used. Follow-up of patients at 3 months after the insertion of the perforated punctal plugs showed that 80% 
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Figure 2. Stepwise approach for perforated punctal plug insertion: (A) Dilation of the lower punctum with a punctal dilator. (B) 
Probing of the lacrimal passages. (C) and (D) Insertion of perforated punctal plug into the lower punctum.
Table 1. Comparing patency of punctum between Group A (lacrimal stenting procedure) versus Group B (three-snip punctoplasty), 
and between two subgroups in Group A (A1: perforated punctal plug; A2: closed intubation using bicanalicular silicon tube)
 Group A Group B P-value1 P-value2
Group A1 Group A2




















1 w 10 (77) 3 (23) 0 (0) 12 (100) 0 (0) 0 (0) 21 (84) 4 (16) 0 (0) 0.04 0.32
1 m 10 (77) 3 (23) 0 (0) 9 (75) 3 (25) 0 (0) 14 (56) 10 (40) 1 (4) 0.80 0.030
3 m 7 (54) 6 (46) 0 (0) 9 (75) 3 (25) 0 (0) 12 (48) 12 (48) 1 (4) 0.01 0.002
6 m 7 (54) 6 (46) 0 (0) 9 (75) 3 (25) 0 (0) 12 (48) 12 (48) 1 (4) 0.01 0.002
Abbreviations: n, number; %, percentage; w, week; m, month. P-value1: comparing Group A1 versus Group A2, and P-value2: comparing 
Group A versus B. P-value < 0.05 is shown in bold.
Table 2. Comparison of patient satisfaction, based on epiphora scoring in follow-up visits, between Group A (lacrimal stenting 
procedure) and Group B (three-snip punctoplasty)
Study Group Group A Group B P-value



















1 w 13 (52) 12 (48) 0 (0) 0 (0) 8 (32) 12 (48) 5 (20) 0 (0) 0.007
1 m 15 (60) 9 (36) 1 (4) 0 (0) 6 (24) 10 (40) 9 (36) 0 (0) 0.001
3 m 11 (44) 9 (36) 5 (20) 0 (0) 6 (24) 10 (40) 8 (32) 1 (4) 0.005
6 m 12 (48) 9 (36) 4 (16) 0 (0) 7 (28) 6 (24) 11 (44) 1 (4) 0.002
Abbreviations: n, number; %, percentage; w, week; m, month. Note: Score 0, no tearing; Score 1, transient tearing outside in windy weather; 
Score 2, constant tearing, sometimes requiring wiping; Score 3, constant tearing, requiring wiping. Abbreviations: n, number; %, percentage; 
w, week; m, month. P-value: for comparing Group A versus B (P-value < 0.05 is shown in bold).
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Table 3. Comparing the external size of the punctum and the FDT in all follow-up visits between Group A (lacrimal stenting procedure) versus 
Group B (three-snip punctoplasty)





External size of the punctum (µm) 1 w 377 ± 34 357 ± 54 0.12
1 m 489 ± 86 390 ± 64 0.009
3 m 463 ± 91 377 ± 51 0.01
6 m 455 ± 89 365 ± 47 0.02
FDT, minutes 1 w Grade 1, n (%) 12 (48) 7 (28) 0.008
Grade 2, n (%) 13 (52) 12 (48)
Grade 3, n (%) 0 (0) 6 (24)
1 m Grade 1, n (%) 15 (60) 6 (24) 0.0001
Grade 2, n (%) 9 (36) 10 (40)
Grade 3, n (%) 1 (4) 9 (36)
3 m Grade 1, n (%) 11 (44) 5 (20) 0.003
Grade 2, n (%) 10 (40) 10 (40)
Grade 3, n (%) 4 (16) 10 (40)
6 m Grade 1, n (%) 13 (52) 5 (20) 0.002
Grade 2, n (%) 7 (28) 8 (32)
Grade 3, n (%) 5 (20) 12 (48)
Abbreviations: SD, standard deviation; µm, micrometer; w, week; m, month; FDT, fluorescein dye disappearance test; n, number; %, 
percentage; P-value: for comparing Group A versus B (P-value < 0.05 is shown in bold). Note: Grade 1, < 3 min; Grade 2, 3–5 min; Grade 3, > 5 min. 
of patients experienced no tearing or sometimes tearing, and only 20% continued to complain of tearing. After 
6 months, the percentages remained the same. Perforated punctal plug insertion is an easy and rapid procedure 
that can be performed under local anesthesia, with a high success rate [16]. It also ensures the drainage of tears 
by a natural method, thus avoiding damage to the lacrimal sphincter and canaliculus. Furthermore, it secures the 
patency of the lacrimal puncta without consequential bleeding or scarring. We believe that this procedure would 
help to avoid repeated dilation of the lacrimal puncta, thus shortening the follow-up period. On the other hand, 
perforated punctal plug insertion is sometimes difficult or leads to laceration [5]. In our study, we encountered 
difficult insertion in two cases; however, good dilation and probing of the lacrimal passages and using the proper 
plug size helped to avoid difficult insertion.
In our study, another group of patients underwent closed intubation using a bicanalicular silicone tube for the 
management of punctal stenosis, which also yielded excellent outcomes. Ideal stents should be inert, flexible, 
have a soft external surface, be self-retaining, inexpensive, widely accessible, user-friendly, and should not induce 
mechanical damage to contiguous soft tissues. Silicon tubes have most of the above-mentioned properties [17-
19]. We used bicanalicular silicon tube insertion in 12 eyes, and removed them after 6 months. We found that 
75% of these cases achieved an open punctum. Seventy-five percent of patients were highly satisfied, with no 
tearing postoperatively, 8% were moderately satisfied, although they complained of sometimes tearing, and 17% 
had a low degree of satisfaction as they experienced recurrence of epiphora.
The main complications of lacrimal stents include stent prolapse or loss, which may require repositioning or 
replacement. Direct visualization using nasal endoscopy is possible. Other complications include punctal slitting 
or cheese wiring caused by excessive bicanalicular stent loop tightening or inferior pulling, punctal or ostium 
granuloma formation with prolonged intubation, secondary bacterial or fungal infections, and rarely, corneal 
erosions and infections [20]. We found loss of perforated punctal plugs in two eyes and partial extrusion of 
perforated punctal plugs in one eye. Moreover, we detected lacrimal tube prolapse in one eye and cheese wiring 
in another eye. We removed the silicone tube after 6 months. However, the debate about the ideal timing for stent 
removal still exists. It is generally recommended to remove the stent between 3 and 6 months after placement. 
Retaining the stent for a longer time may cause granuloma formation or pyogenic infection [21]. In the current 
study, no such complications were observed related to the lacrimal stents.
According to our results, lacrimal stenting procedures (either closed intubation or perforated punctal plug 
insertion) seem to be superior to three-snip punctoplasty in terms of anatomical and functional success. At the 
1-week follow-up, the punctum was open in 88% of cases with lacrimal stenting and in 84% of cases with three-
snip punctoplasty. After 1-month, the punctum was open in 76% of cases with lacrimal stenting and in 56% of 
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cases with three-snip punctoplasty. After 6 months, the punctum was open in 65% of cases with lacrimal stenting 
and in 48% of cases with three-snip punctoplasty.
Although, we demonstrated the superiority of lacrimal stenting procedures over three-snip punctoplasty in 
an open-label, randomized clinical trial. However, the main limitation of this trial was the small sample size, as 
we included only 50 eyes due to cost-related issues. Another limitation was the relatively short follow-up period, 
which may not confirm the long-term efficacy of lacrimal stenting. We acknowledge that a larger sample size 
with a longer duration of follow-up could provide more robust and reliable results. Therefore, we would suggest 
designing future studies to address these limitations.
CONCLUSIONS
Our results confirmed the efficacy of lacrimal stenting, either closed intubation or perforated plug insertion, 
for the treatment of punctal stenosis or occlusion, which yielded significantly better anatomical and functional 
results and patient satisfaction outcomes than three-snip punctoplasty in patients with punctal stenosis or 
occlusion.
ETHICAL DECLARATIONS
Ethical approval: This open-label, non-randomized clinical trial received institutional review board approval 
from the Faculty of Medicine, Sohag University, Egypt, before commencement. All participants provided 
informed consent after receiving an explanation of the study procedures. This clinical trial was registered at 
the Pan African Clinical Trial Registry (PACTR; registration number PACTR201801002952201) and was 
conducted in accordance with the tenets of the Declaration of Helsinki. 




The authors are grateful to Prof. Gamal Radwan and Prof. Ahmed Mostafa for their great help and support.
REFERENCES
1. Kashkouli MB, Beigi B, Murthy R, Astbury N. Acquired external punctal stenosis: etiology and associated findings. American Journal of 
Ophthalmology. 2003;136(6):1079-84. doi: 10.1016/s0002-9394(03)00664-0 pmid: 14644218
2. Soiberman U, Kakizaki H, Selva D, Leibovitch I. Punctal stenosis: definition, diagnosis, and treatment. Clin Ophthalmol. 2012;6:1011-8. 
doi: 10.2147/OPTH.S31904 pmid: 22848141
3. Bukhari A. Prevalence of punctal stenosis among ophthalmology patients. Middle East Afr J Ophthalmol. 2009;16(2):85-7. doi: 
10.4103/0974-9233.53867 pmid: 20142967
4. Singh M, Gautam N, Ahir N, Kaur M. Is the distance from punctum a factor in the anatomical and functional success of canalicular lacer-
ation repairs? Indian J Ophthalmol. 2017;65(11):1114-9. doi: 10.4103/ijo.IJO_499_17 pmid: 29133635
5. Ozgur OR, Akcay L, Tutas N, Karadag O. Management of acquired punctal stenosis with perforated punctal plugs. Saudi J Ophthalmol. 
2015;29(3):205-9. doi: 10.1016/j.sjopt.2015.04.001 pmid: 26155080
6. Ma’luf RN, Hamush NG, Awwad ST, Noureddin BN. Mitomycin C as adjunct therapy in correcting punctal stenosis. Ophthalmic Plast 
Reconstr Surg. 2002;18(4):285-8. doi: 10.1097/00002341-200207000-00010 pmid: 12142762
7. Fraser CE, Petrakos P, Lelli GJ, Jr. Adjunctive re-dilation for early cicatrization after punctoplasty. Orbit. 2012;31(5):313-5. doi: 
10.3109/01676830.2012.681751 pmid: 22616663
8. Gupta S, Ali MJ, Ali MH, Naik MN. Assessing the outcomes of mini-Monoka stent dilatation for primary punctal stenosis using the 
lacrimal symptom questionnaire. Indian J Ophthalmol. 2018;66(2):269-71. doi: 10.4103/ijo.IJO_799_17 pmid: 29380772
9. Boldin I, Klein A, Haller-Schober EM, Horwath-Winter J. Long-term follow-up of punctal and proximal canalicular stenoses after sil-
icone punctal plug treatment in dry eye patients. Am J Ophthalmol. 2008;146(6):968-72 e1. doi: 10.1016/j.ajo.2008.06.028 pmid: 
18723140
10. Munk PL, Lin DT, Morris DC. Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage 
apparatus. Radiology. 1990;177(3):687-90. doi: 10.1148/radiology.177.3.2243969 pmid: 2243969
11. Malet T, Challier B, David N, Bertrand A, George JL. Clinical and scintigraphic comparison of silicone and polyvinylpyrrolidone coated 
silicone perforated plugs. Br J Ophthalmol. 1998;82(12):1416-9. doi: 10.1136/bjo.82.12.1416 pmid: 9930274
12. Shahid H, Sandhu A, Keenan T, Pearson A. Factors affecting outcome of punctoplasty surgery: a review of 205 cases. Br J Ophthalmol. 
2008;92(12):1689-92. doi: 10.1136/bjo.2008.140681 pmid: 18786958
13. Chalvatzis NT, Tzamalis AK, Mavrikakis I, Tsinopoulos I, Dimitrakos S. Self-retaining bicanaliculus stents as an adjunct to 3-snip punc-
toplasty in management of upper lacrimal duct stenosis: a comparison to standard 3-snip procedure. Ophthalmic Plast Reconstr Surg. 
2013;29(2):123-7. doi: 10.1097/IOP.0b013e31827f5a10 pmid: 23392314
14. Hussain RN, Kanani H, McMullan T. Use of mini-monoka stents for punctal/canalicular stenosis. Br J Ophthalmol. 2012;96(5):671-3. 
doi: 10.1136/bjophthalmol-2011-300670 pmid: 22241928
Lacrimal stenting versus three-snip punctoplasty 
Med Hypothesis Discov Innov Ophthalmol. 2021; 10(1) 31
15. Konuk O, Urgancioglu B, Unal M. Long-term success rate of perforated punctal plugs in the management of acquired punctal stenosis. 
Ophthalmic Plast Reconstr Surg. 2008;24(5):399-402. doi: 10.1097/IOP.0b013e318185a9ca pmid: 18806663
16. Chang M, Ahn SE, Baek S. The effect of perforated punctal plugs in the management of acquired punctal stenosis. J Craniofac Surg. 
2013;24(5):1628-30. doi: 10.1097/SCS.0b013e318292c68b pmid: 24036740
17. Alsulaiman N, Alsuhaibani AH. Bicanalicular Silicone Intubation for the Management of Punctal Stenosis and Obstruction in Pa-
tients With Allergic Conjunctivitis. Ophthalmic Plast Reconstr Surg. 2019;35(5):451-5. doi: 10.1097/iop.0000000000001315 pmid: 
30844917
18. Ahmed RA, Azzam SA. Management of acquired punctal stenosis in trachomatous patients using single versus double silicone tube 
insertion (a pilot study). Kasr Al Ainy Medical Journal. 2016;22(1):1. doi: 10.4103/1687-4625.182551 
19. Ullrich K, Malhotra R, Patel BC. Dacryocystorhinostomy. 2021 Feb 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Pub-
lishing; 2021 Jan–. pmid: 32496731
20. Repka MX, Chandler DL, Holmes JM, Hoover DL, Morse CL, Schloff S, et al. Balloon catheter dilation and nasolacrimal duct intubation 
for treatment of nasolacrimal duct obstruction after failed probing. Arch Ophthalmol. 2009;127(5):633-9. doi: 10.1001/archophthal-
mol.2009.66 pmid: 19433712
21. Ali MJ, Psaltis AJ, Ali MH, Wormald PJ. Endoscopic assessment of the dacryocystorhinostomy ostium after powered endoscopic surgery: 
behaviour beyond 4 weeks. Clin Exp Ophthalmol. 2015;43(2):152-5. doi: 10.1111/ceo.12383 pmid: 24995830
